Literature DB >> 24628034

Fibronectin-binding proteins are required for biofilm formation by community-associated methicillin-resistant Staphylococcus aureus strain LAC.

Jennifer McCourt1, Dara P O'Halloran, Hannah McCarthy, James P O'Gara, Joan A Geoghegan.   

Abstract

Community-associated methicillin-resistant Staphylococcus aureus of the USA300 lineage is emerging as an important cause of medical device-related infection. However, few factors required for biofilm accumulation by USA300 strains have been identified, and the processes involved are poorly understood. Here, we identify S. aureus proteins required for the USA300 isolate LAC to form biofilm. A mutant with a deletion of the fnbA and fnbB genes did not express the fibronectin-binding proteins FnBPA and FnBPB and lacked the ability to adhere to fibronectin or to form biofilm. Biofilm formation by the mutant LAC∆fnbAfnbB could be restored by expression of FnBPA or FnBPB from a plasmid demonstrating that both of these proteins can mediate biofilm formation when expressed by LAC. Expression of FnBPA and FnBPB increased bacterial aggregation suggesting that fibronectin-binding proteins can promote the accumulation phase of biofilm. Loss of fibronectin-binding proteins reduced the initial adherence of bacteria, indicating that these proteins are also involved in primary attachment. In summary, these findings improve our understanding of biofilm formation by the USA300 strain LAC by demonstrating that the fibronectin-binding proteins are required.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  CA-MRSA; bacterial adhesion; pathogenicity; virulence factor

Mesh:

Substances:

Year:  2014        PMID: 24628034     DOI: 10.1111/1574-6968.12424

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  56 in total

Review 1.  Staphylococcus aureus biofilm: a complex developmental organism.

Authors:  Derek E Moormeier; Kenneth W Bayles
Journal:  Mol Microbiol       Date:  2017-03-08       Impact factor: 3.501

2.  Fibronectin-binding protein B (FnBPB) from Staphylococcus aureus protects against the antimicrobial activity of histones.

Authors:  Giampiero Pietrocola; Giulia Nobile; Mariangela J Alfeo; Timothy J Foster; Joan A Geoghegan; Vincenzo De Filippis; Pietro Speziale
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

Review 3.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

4.  Genetic and Biochemical Analysis of CodY-Mediated Cell Aggregation in Staphylococcus aureus Reveals an Interaction between Extracellular DNA and Polysaccharide in the Extracellular Matrix.

Authors:  Kevin D Mlynek; Logan L Bulock; Carl J Stone; Luke J Curran; Marat R Sadykov; Kenneth W Bayles; Shaun R Brinsmade
Journal:  J Bacteriol       Date:  2020-03-26       Impact factor: 3.490

5.  Contribution of Streptococcus mutans Strains with Collagen-Binding Proteins in the Presence of Serum to the Pathogenesis of Infective Endocarditis.

Authors:  Masatoshi Otsugu; Ryota Nomura; Saaya Matayoshi; Noboru Teramoto; Kazuhiko Nakano
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

6.  MgrA Negatively Impacts Staphylococcus aureus Invasion by Regulating Capsule and FnbA.

Authors:  Mei G Lei; Dereje D Gudeta; Thanh T Luong; Chia Y Lee
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

7.  Surface proteins and the formation of biofilms by Staphylococcus aureus.

Authors:  Sung Joon Kim; James Chang; Binayak Rimal; Hao Yang; Jacob Schaefer
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-12-09       Impact factor: 3.747

8.  Effects of Low-Dose Amoxicillin on Staphylococcus aureus USA300 Biofilms.

Authors:  Kevin D Mlynek; Mary T Callahan; Anton V Shimkevitch; Jackson T Farmer; Jennifer L Endres; Mélodie Marchand; Kenneth W Bayles; Alexander R Horswill; Jeffrey B Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

9.  In Vivo Gentamicin Susceptibility Test for Prevention of Bacterial Biofilms in Bone Tissue and on Implants.

Authors:  Louise Kruse Jensen; Thomas Bjarnsholt; Kasper N Kragh; Bent Aalbæk; Nicole Lind Henriksen; Sophie Amalie Blirup; Karen Pankoke; Andreas Petersen; Henrik Elvang Jensen
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

10.  Modulation of Staphylococcus aureus Biofilm Matrix by Subinhibitory Concentrations of Clindamycin.

Authors:  Katrin Schilcher; Federica Andreoni; Vanina Dengler Haunreiter; Kati Seidl; Barbara Hasse; Annelies S Zinkernagel
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.